PHYTOTHERAPEUTIX LTD

Company Registration Number:
11955219 (England and Wales)

Unaudited statutory accounts for the year ended 31 March 2025

Period of accounts

Start date: 1 April 2024

End date: 31 March 2025

PHYTOTHERAPEUTIX LTD

Contents of the Financial Statements

for the Period Ended 31 March 2025

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

PHYTOTHERAPEUTIX LTD

Directors' report period ended 31 March 2025

The directors present their report with the financial statements of the company for the period ended 31 March 2025

Directors

The directors shown below have held office during the whole of the period from
1 April 2024 to 31 March 2025

Mr Colin Stott
Mr Dominic Schiller
Mr Timothy Rogers


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
30 December 2025

And signed on behalf of the board by:
Name: Mr Colin Stott
Status: Director

PHYTOTHERAPEUTIX LTD

Profit And Loss Account

for the Period Ended 31 March 2025

2025 2024


£

£
Administrative expenses: ( 1,239 ) 0
Operating profit(or loss): (1,239) 0
Interest payable and similar charges: ( 21 )
Profit(or loss) before tax: (1,260) 0
Profit(or loss) for the financial year: (1,260) 0

PHYTOTHERAPEUTIX LTD

Balance sheet

As at 31 March 2025

Notes 2025 2024


£

£
Current assets
Stocks: 3 799 799
Cash at bank and in hand: 144 1,004
Total current assets: 943 1,803
Creditors: amounts falling due within one year: 4 ( 27,365 ) ( 27,365 )
Net current assets (liabilities): (26,422) (25,562)
Total assets less current liabilities: (26,422) ( 25,562)
Creditors: amounts falling due after more than one year: 5 ( 6,073 ) ( 5,673 )
Total net assets (liabilities): (32,495) (31,235)
Capital and reserves
Called up share capital: 1 1
Profit and loss account: (32,496 ) (31,236 )
Total Shareholders' funds: ( 32,495 ) (31,235)

The notes form part of these financial statements

PHYTOTHERAPEUTIX LTD

Balance sheet statements

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 30 December 2025
and signed on behalf of the board by:

Name: Mr Colin Stott
Status: Director

The notes form part of these financial statements

PHYTOTHERAPEUTIX LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Other accounting policies

    Basis of preparation - The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss. The financial statements are prepared in sterling, which is the functional currency of the entity. Taxation - The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference. Stocks - Stocks Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.

PHYTOTHERAPEUTIX LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

  • 2. Employees

    2025 2024
    Average number of employees during the period 3 3

PHYTOTHERAPEUTIX LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

3. Stocks

2025 2024
£ £
Stocks 799 799
Total 799 799

PHYTOTHERAPEUTIX LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

4. Creditors: amounts falling due within one year note

2025 2024
£ £
Other creditors 27,365 27,365
Total 27,365 27,365

PHYTOTHERAPEUTIX LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

5. Creditors: amounts falling due after more than one year note

2025 2024
£ £
Other creditors 6,073 5,673
Total 6,073 5,673

PHYTOTHERAPEUTIX LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

6. Loans to directors

Name of director receiving advance or credit: Mr Colin Stott
Description of the transaction:
Mr Colin Stott had made loans to the company in prior years.
£
Balance at 31 March 2024 19,410
Advances or credits made:
Advances or credits repaid:
Balance at 31 March 2025 19,410